Literature DB >> 9250173

Presenilin-1 is associated with Alzheimer's disease amyloid.

T Wisniewski1, W K Dowjat, B Permanne, J Palha, A Kumar, G Gallo, B Frangione.   

Abstract

Mutations in presenilin (PS)-1 and -2, located on chromosome 14 and 1 respectively, are the major association with early-onset familial Alzheimer's disease (FAD). FAD has also been linked to mutations in the amyloid beta precursor protein (beta PP), and the presence of the apolipoprotein E4 allele is a risk factor for late-onset AD. The role of PS in FAD and in sporadic AD is unclear. We previously reported the presence of a PS-1 carboxyl-terminal epitope in neuritic plaques (Wisniewski T, Palha JA, Ghiso J, Frangione B: S182 protein in Alzheimer's disease neuritic plaques. Lancet 1995, 346:1366). In the present study, we examined a number of biochemically different cerebral and systemic amyloidoses, finding the PS-1 carboxy epitope only in association with amyloid beta (A beta) lesions. We confirm the presence of this epitope ultrastructurally in neuritic plaques. In addition, biochemical and amino acid sequence data are presented for an association of the 18-kd carboxy fragment of PS-1 with neuritic plaques with a start at residue 300. Three of the proteins with linkage to AD have now been found as components of neuritic plaques. It remains to be determined whether all of these proteins are involved in the same or different pathological pathway(s) and which of these proteins is the most important for the common, late-onset form of AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250173      PMCID: PMC1858010     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters.

Authors:  K D Phend; R J Weinberg; A Rustioni
Journal:  J Histochem Cytochem       Date:  1992-07       Impact factor: 2.479

Review 2.  The gene defects responsible for familial Alzheimer's disease.

Authors:  R E Tanzi; D M Kovacs; T W Kim; R D Moir; S Y Guenette; W Wasco
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

3.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

4.  Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.

Authors:  J Näslund; J Thyberg; L O Tjernberg; C Wernstedt; A R Karlström; N Bogdanovic; S E Gandy; L Lannfelt; L Terenius; C Nordstedt
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

5.  Is Alzheimer's disease an apolipoprotein E amyloidosis?

Authors:  T Wisniewski; M Lalowski; A Golabek; T Vogel; B Frangione
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

Review 6.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

7.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.

Authors:  E I Rogaev; R Sherrington; E A Rogaeva; G Levesque; M Ikeda; Y Liang; H Chi; C Lin; K Holman; T Tsuda
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

8.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus.

Authors:  E Levy-Lahad; W Wasco; P Poorkaj; D M Romano; J Oshima; W H Pettingell; C E Yu; P D Jondro; S D Schmidt; K Wang
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

9.  A familial Alzheimer's disease locus on chromosome 1.

Authors:  E Levy-Lahad; E M Wijsman; E Nemens; L Anderson; K A Goddard; J L Weber; T D Bird; G D Schellenberg
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  5 in total

Review 1.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 2.  Alzheimer's disease and brain development: common molecular pathways.

Authors:  K Jordan-Sciutto; R Bowser
Journal:  Front Biosci       Date:  1998-01-15

3.  Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures.

Authors:  G Bråthen; K S Bjerve; E Brodtkorb; G Bovim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

4.  Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.

Authors:  V Askanas; W K Engel; C C Yang; R B Alvarez; V M Lee; T Wisniewski
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 5.  ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease.

Authors:  Somya Patro; Sujay Ratna; Hianny A Yamamoto; Andrew T Ebenezer; Dillon S Ferguson; Amanpreet Kaur; Brendan C McIntyre; Ryan Snow; Maria E Solesio
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.